4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008622
CHIEF FINANCIAL OFFICER sold 20,343 shares at $23.10 ($469,923)
- CHIEF FINANCIAL OFFICER acquired 21,215 shares (option exercise)
- CHIEF FINANCIAL OFFICER gave up 448 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-16 | Option exercise 10b5-1 | +872 | 23,830 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-16 | Shares withheld for taxes 10b5-1 | −448 | $22.61 | $10,129 | 23,382 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-17 | Option exercise 10b5-1 | +11,464 | $12.97 | $148,688 | 34,846 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-17 | Sale 10b5-1 | −11,464 | $23.10 | $264,818 | 23,382 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-19 | Option exercise 10b5-1 | +8,879 | $12.97 | $115,161 | 32,261 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-19 | Sale 10b5-1 | −8,879 | $23.10 | $205,105 | 23,382 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-16 | Option exercise · Restricted Share Unit 10b5-1 | −872 | 0 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-17 | Option exercise · Share Option 10b5-1 | −11,464 | 33,197 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-19 | Option exercise · Share Option 10b5-1 | −8,879 | 24,318 | D | ||
| Open-market sales · 20,343 sh · avg $23.10 · $469,923 | |||||||
Loading xslF345X05/form4-03192025_090329.xml…